Kang Lab – Hematologic Malignancies and Cellular Therapy at Duke University

Parker Mathews joined the lab on 4/1/19 to serve as our new lab manager.

Daniel Feinberg was accepted to the MD, PhD program at Case Western University/Cleveland Clinic and will be moving to Cleveland to pursue his education. Congrats Daniel!

Barry Paul accepted a hematologist/oncologist position at the Levine Cancer Center in Charlotte, NC. Congratulations!

Congratulations to Dr. Jing Zheng and Dr. Yonggang Sha for their co-first author paper published in Cancer Letter entitled “Pan-PIM kinase inhibitors enhance Lenalidomide’s anti-myeloma activity via cereblon-IKZF1/3 cascade”.

Kudos to Dr. Zhihong Zheng for her paper entitled “Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma” was published by Journal of Hematology and Oncology!

Congrats to Pasupathi Sundaramoorthy for the acceptance of his paper in Stem Cell Research & Therapy on “Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice” in which he discovers a key role of thioredoxin in the regulation of radiation-induced hematopoietic stem cell injury. Great job!